Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU

Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU is a phase 2, interventional study registered as NCT07391618 by Chinese PLA General Hospital, with a registry enrolment figure of 583 participants, started 2025-05-15 and due to reach its primary completion in 2028-12. Interventions recorded: mFOLFOX/FOLFIRI ( Standard Chemotherapy). Conditions listed: Advanced Colorectal Cancer. Primary outcome: PFS. Colorectal eligibility wording from the registry: "Patients with unresectable or metastatic colorectal cancer confirmed by histology or cytology, where the primary tumor location and the status of RAS and BRAF are known;". Sites: China. No results are recorded here; the registry entry is the source.